Pharmaceutical Executive-12-01-2021

2022 Pipeline Report: Capitalizing on Opportunity

December 09, 2021

Features

41

12

Our annual report takes a look at pharma’s current investment in drug development, which this year demonstrates a focus on five important therapeutic areas of interest—Alzheimer’s disease, ophthalmology, NASH, anti-infectives, and opioids.

Oncology Optimist

December 09, 2021

Executive Profile

41

12

After two decades at the forefront of hematology and oncology drug development, AbbVie’s vice president and global head of oncology clinical development, Mohamed Zaki, MD, PhD, is more hopeful than ever about recent advances in the space.